Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Study shows L-methylfolate, when administered alongside standard therapy for glioblastomas, changed the DNA process within a patients tumour
An ultrasound can diagnose most prostate cancer cases in men with great accuracy – only missing 3.4% of severe cases.
Lester Litchfield, Data & Science Manager, Volpara Health, explores how to build confidence in the use of AI for mammography clinical practice Artificial Intelligence (AI)...
Analysis of 28 studies has found that the intersection of sexual minority status with ethnicity is associated with lower cancer screenings.
Researchers analysing dietary habits find that those who consume meat five times or less weekly have a lower cancer risk.
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Chair of Medical Cell BioPhysics Leon WMM Terstappen highlights why the interrogation of the cancer cells at the single cell level is required to truly understand cancer development.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.
The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
An ongoing clinical trial led by the NCI Centre for Cancer Research reveals an experimental form of immunotherapy for metastatic breast cancer.
The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.
Scientists invented the ‘falloposcope’ to detect early-stage ovarian cancer - now, making history, a surgeon successfully used the device to capture images of fallopian tubes.
A survey points out the low number of cervical cancer screenings across the US, whilst examining which demographics are being hit the hardest.
A new minimally invasive and inexpensive blood test can detect a range of cancers in patients with non-specific symptoms, and can indicate whether the cancer has spread.
Members of the Breast Cancer & Environment Research Program walk us through what we need to know about oestrogen signalling, including environmental chemicals & links with breast cancer.
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy